Login to Your Account



Earnings Roundup


Wednesday, April 25, 2012
• Alexion Pharmaceuticals Inc., of Cheshire, Conn., reported net product sales of Soliris (eculizumab) of $244.7 million for the first quarter, an increase of 47 percent for the same period in 2011.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription